The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...

An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The advisory committee, which met after the agency rolled out new vaccine guidelines, said companies should tailor their ...

The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

The U.S. government has not yet made its official recommendations for who should be able to get COVID booster shots this fall ...

New guidelines for COVID vaccine. Prior to the new guidelines, it was recommended that everyone who is 6 months and older get ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...